Risperidone versus haloperidol for perception of emotion in treatment- resistant schizophrenia: Preliminary findings

Schizophrenia Research

Volumn 31, Issue 2-3, 1998, Pages 159-165

  Kee, Kimmy S ^a,b   Kern, Robert S ^a,b   Marshall Jr , Barringer D ^c   Green, Michael F ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UCLA Dept Psychiat B   (United States)

Author keywords

Emotion perception; Haloperidol; Risperidone; Schizophrenia

Indexed keywords

HALOPERIDOL; RISPERIDONE;

ADULT; AFFECT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG RESISTANCE; EMOTION; FACIAL EXPRESSION; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; VOICE;

ADULT; ANALYSIS OF VARIANCE; ANTIPSYCHOTIC AGENTS; DOUBLE-BLIND METHOD; DRUG RESISTANCE; EMOTIONS; FEMALE; HALOPERIDOL; HUMANS; MALE; RISPERIDONE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT OUTCOME;

EID: 0032565597     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(98)00026-7     Document Type: Article

References (24)

1. Bellack, A.S., Blanchard, J.J., Mueser, K.T., 1996. Cue availability and affect perception in schizophrenia. Schizophr. Bull. 22 (3), 535-544.
2. Chouinard, G., Jones, B., Remington, G., Bloom, D., Addington, D., MacEwan, G.W., Labelle, A., Beauclair. L., Arnott. W.A., 1993. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients. J. Clin. Psychopharmacol. 13 (1). 25-40.
3. Claus, A., Bollen, J., De Cuyper, H., Eneman, M., Malfroid, M., Peuskens, J., Heylen, S., 1992. Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: a multicentre double-blind comparative study. Acta Psychiatr. Scand. 85, 295-305.
4. Corbett, R., Hartman, H., Kerman, L.L., Woods, A.T., Strupczewski, J.T., Helsley, G.C., Conway, P.C., Dunn, R. W., 1993. Effects of atypical antipsychotic agents on social behavior in rodents. Pharmacol. Biochem. Behav. 45, 9-17.
5. Dougherty, E.E., Bartlett. E.S., Izard, C.E., 1974. Responses of schizophrenics to expressions of fundamental emotions. J. Clin. Psychol. 30. 243-246.
6. Ekman, P., 1976. Pictures of Facial Affect. Consulting Psychologists Press, Palo Alto, CA.
7. Gaebel. W., Wolwer, W., 1992. Facial expression and emotional face recognition in schizophrenia and depression. Eur. Arch. Psychiatry Clin. Neurosci. 242, 46-52.
8. Green, M.F., Marshall Jr., B.D.. Wirshing, W.C., Ames, D., Marder, S.R., McGurk, S., Kern, R.S.. Mintz, J.. 1997. Does risperidone improve verbal working memory in treatment-resistant schizophrenia? Am. J. Psychiatry 154, 799-804.
9. Izard, C.E., 1971. The Face of Emotion. Appleton-Century-Crofts. New York.
10. Kane, J., Honigfield, G., Singer, J.. Meltzer. H., Group. C.C.S., 1988. Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chloropromazine. Arch. Gen. Psychiatry 45, 789-796.
11. Kerr, S.L., Neale, J.M., 1993. Emotion perception in schizophrenia: specific deficit or further evidence of generalized poor performance? J. Abnorm. Psychol. 102 (2), 312-318.
12. Marder, S.R., Meibach, R.C., 1994. Risperidone in the treatment of schizophrenia. Am. J. Psychiatry 151 (6), 825-835.
13. Morrison, R.L., Bellack, A.S., 1981. The role of social perception in social skill. Behav. Ther. 12, 69-72.
14. Morrison, R.L., Bellack, A.S., Mueser. K.T., 1988. The social functioning of schizophrenia patients: clinical and research issues. Schizophr. Bull. 13. 715-726.
15. Mueser, K.T., Bellack, A.S., Wade. J.H., Sayers, S.L., Tierney, A.. Haas, G., 1993. Expressed emotion, social skill, and response to negative affect in schizophrenia. J. Abnormal. Psychol. 102, 339-351.
16. Mueser, K.T., Doonan, R., Penn, D.L., Blanchard, J.J.. Bellack, A.S., Nishith, P., DeLeon, J., 1996. Emotion recognition and social competence in chronic schizophrenia. J. Abnorm. Psychol. 105. 271-275.
17. Rosen, A.J., Mueser, K.T., Sussman, S., Davis, J.M., 1981. The effects of neuroleptic drugs on the social interaction of hospitalized psychotic patients. J. Nerv. Ment. Dis. 169, 240-243.
18. Salem, J.E., Kring. A.M., Kerr, S.L., 1996. More evidence for generalized poor performance in facial emotion perception in schizophrenia. J. Abnorm. Psychol. 105, 480-483.
19. Schneider, F., Gur, R.C., Gur, R.E., Shtasel, D.L., 1995. Emotional processing in schizophrenia: neurobehavioral probes in relation to psychopathology. Schizophr. Res. 17, 67-75.
20. Spitzer, R.L., Williams, J.B.W., Miriam, G., First, M.B., 1990. Structured Clinical Interview for DSM-III-R - Patient Edition (SCID-P. Version 1.0). American Psychiatric Press, Washington, DC.
21. Stip, E., Lussier, I., 1996. The effect of risperidone on cognition in patients with schizophrenia. Can. J. Psychiatry 41 (2), 35-40.
22. Ventura, J., Lukoff, D., Nuechterlein, K.H., Liberman, R.P., Green, M., Shaner, A.. 1993. Brief Psychiatric Rating Scale (BPRS). Int. J. Methods Psychiatr. Res. 3, 227-241.
23. Walker, E., McGuire, M., Bettes, B., 1984. Recognition and identification of facial stimuli by schizophrenics and patients with affective disorders. Br. J. Clin. Psychol. 23, 37-44.
24. Wallace, C.J., 1984. Community and interpersonal functioning in the course of schizophrenic disorders. Schizophr. Bull. 10 (2), 233-257.